Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 06, 2024 08:10 ET | Source: Gallant Therapeutics

Gallant Therapeutics Adds Animal Health Executive Aaron Schacht to Board of Directors

Gallant Therapeutics Adds Animal Health Executive Aaron Schacht to Board of Directors
January 08, 2024 08:00 ET | Source: Gallant Therapeutics

Gallant Therapeutics Raises Over $15 Million in Series A Funding to Advance Pipeline of "Off-the-Shelf" Stem Cell Therapies for Pets

Gallant Therapeutics Raises Over $15 Million in Series A Funding to Advance Pipeline of "Off-the-Shelf" Stem Cell Therapies for Pets
December 06, 2023 08:19 ET | Source: Gallant Therapeutics

Gallant Therapeutics Announces Launch of JEDI Pivotal Study for First Allogeneic Stem Cell Therapy Targeting Feline Chronic Gingivostomatitis

Gallant Therapeutics Announces Launch of JEDI Pivotal Study for First Allogeneic Stem Cell Therapy Targeting Feline Chronic Gingivostomatitis
October 03, 2023 08:12 ET | Source: Gallant Therapeutics

Ethos Discovery and Gallant Therapeutics Collaborate on Study Evaluating Gallant’s Stem Cell Therapy in Pugs with Necrotizing Meningoencephalitis (NME), also referred to as Pug Dog Encephalitis (PDE)

Gallant Therapeutics and Ethos Discovery collaborate in a clinical study evaluating the use of stem cells to treat pugs with early-stage NME